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Abstract
Specific ceramides are key regulators of cell fate, and extensive studies aimed to develop therapies based on
ceramide-induced cell death. However, the mechanisms regulating ceramide cytotoxicity are not yet fully elucidated.
Since ceramides also regulate growth and stress responses in yeast, we studied how different exogenous ceramides
affect yeast cells. C2-phytoceramide, a soluble form of phytoceramides, the yeast counterparts of mammalian
ceramides, greatly reduced clonogenic survival, particularly in the G2/M phase, but did not induce autophagy nor
increase apoptotic markers. Rather, the loss of clonogenic survival was associated with PI positive staining,
disorganization of lipid rafts and cell wall weakening. Sensitivity to C2-phytoceramide was exacerbated in mutants
lacking Hog1p, the MAP kinase homolog of human p38 kinase. Decreasing sterol membrane content reduced
sensitivity to C2-phytoceramide, suggesting sterols are the targets of this compound. This study identified a new
function of C2-phytoceramide through disorganization of lipid rafts and induction of a necrotic cell death under hypo-
osmotic conditions. Since lipid rafts are important in mammalian cell signaling and adhesion, our findings further
support pursuing the exploitation of yeast to understand the basis of synthetic ceramides’ cytotoxicity to provide novel
strategies for therapeutic intervention in cancer and other diseases.
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Introduction
Ceramide has emerged as an important second-messenger
lipid with proposed roles in a wide range of cellular processes
such as cell growth, differentiation, apoptosis, stress
responses, and senescence. Ceramide can activate enzymes
involved in signaling cascades comprising both protein kinases
and phosphatases, such as ceramide-activated protein kinase
(CAPK) and ceramide-activated protein phosphatases (CAPPs)
[1]. CAPK regulates several kinases, including the mitogen
activated protein kinase (MAPK) ERK (extracellular-signal
regulated kinase), leading to cell cycle arrest and cell death,
stress-activated protein kinases (SAPKs) such as the Jun
kinases (JNKs) and p38-MAPK, kinase suppressor of Ras
(KSR), and the atypical protein kinase C (PKC) isoform zeta
[2,3]. Ceramide activation of CAPPs, which comprise the serine
threonine protein phosphatases PP1 and PP2A [1,4], leads to
dephosphorylation and inactivation of several substrates, such
as Bcl-2 and Akt [1], and downregulation of the transcription
factors c-Myc and c-Jun [3,4]. Ceramide and sphingosine
levels increase in response to stress and in apoptosis induced
by several stimuli such as FAS activation and anticancer drugs,
and ceramides regulate mammalian apoptosis by both
transcriptional-dependent and -independent mechanisms [3].
Receptor clustering and apoptosis induced by death ligands,
such as FAS and TNF alpha, involves ceramide generation by
sphingomyelinase acting primary in lipid rafts [2].
The yeast Saccharomyces cerevisiae has been extensively
used in the elucidation of numerous cellular and molecular
processes that have proven conserved across species, such as
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cell cycle control and apoptosis [5]. Several studies indicate
that the ceramide pathway is a ubiquitous signaling system,
conserved from yeast to human [6]. Exogenous N-
acetylsphingosine (C2-ceramide) specifically inhibited
proliferation of S. cerevisiae, inducing an arrest at G1 phase of
the cell cycle mediated by yeast CAPP [7]. Similarly to
mammalian cells, yeast ceramide levels increase in response
to stress [8], and perturbations in sphingolipid metabolism can
also determine yeast cell fate. Expression of mammalian
sphingomyelin synthase (SMS1) suppresses Bax-mediated
yeast cell death and confers resistance to different apoptotic
inducers [9], suggesting that SMS1, which uses ceramide to
synthesize sphingomyelin, protects cells against death by
counteracting stress-induced accumulation of the pro-apoptotic
ceramide. Yet another study showed that a yeast mutant
deficient in Isc1p, a member of the neutral sphingomyelinase
family, displays increased apoptotic cell death in response to
hydrogen peroxide and during chronological aging [10]. A
lipidomic approach revealed that these phenotypes were
associated with increased levels of dihydro-C26-ceramide and
phyto-C26-ceramide [11]. Very recently it has also been
reported that some phytoceramides contribute to cell death
induced by acetic acid, and are involved in mitochondrial outer
membrane permeabilization [12]. Another study showed that
exogenous C2-ceramide can trigger a mitochondria-mediated
cell death process in yeast [13].
In summary, literature data indicate that exogenous
ceramides and changes in the levels of endogenous
ceramides, as well as other sphingolipids such as sphingosine,
dihydroceramide and phytoceramide, can affect cell fate in
yeast [8]. Since yeast and mammals share many similarities in
sphingolipid metabolism [14], we aimed to explore S.
cerevisiae as a model system to advance our knowledge on
the molecular basis of ceramide-induced cell changes, as well
as of the involvement of signaling pathways in this process. We
show that exogenous C2-phytoceramide (N-acetyl-D-
phytosphyngosine) induces growth arrest in the G0/G1 phases
and loss of clonogenic survival in the G2/M phases. Defects in
cell wall and plasma membrane integrity, resulting in higher
sensitivity to osmotic stress, seem to underlie loss of survival.
C2-phytoceramide disturbed lipid rafts and caused higher
intracellular accumulation of sterols, suggesting the observed
phenotypes are a result of defects in trafficking. We also show
that C2-phytoceramide-treated cells require the HOG (High
Osmolarity Glycerol) pathway for the response against




The yeast S. cerevisiae strain W303-1A (MATa, ura3-52,
trp1Δ 2, leu2-3,112, his3-11, ade2-1, can1-100) was used
throughout this work as the wild type strain. S. cerevisiae strain
BY4741 was also used to test sensitivity to C2-phytoceramide.
All the mutant strains were constructed by replacing the
respective genes in the W303-1A strain with a kanMX4
disruption cassette, amplified by PCR from genomic DNA
purified from the respective Euroscarf deletion strain as
described in the Saccharomyces Genome Deletion Project
database [15].
Media and growth conditions
Cells were maintained on YPD agar plates containing
glucose (2%), yeast extract (1%), peptone (2%) and agar (2%)
and grown in liquid synthetic complete medium (SC) [(0.67%
Yeast nitrogen base without amino acids, galactose (2%),
0.14% drop-out mixture lacking histidine, leucine, tryptophan
and uracil, 0.008% histidine, 0.04% leucine, 0.008% tryptophan
and 0.008% uracil] until mid-exponential phase.
Cell Viability Assays
W303-1A cells grown to mid-exponential-phase (OD600 of
0.5-0.6) were harvested by centrifugation and suspended in SC
galactose (OD600 of 0.2) containing 0.1% of DMSO and C2-
ceramide (N-acetyl-sphingosine), C6-ceramide (N-hexanoil-
sphingosine) or C2-phytoceramide (N-acetyl-D-
phytosphyngosine) at the indicated concentrations. Treatments
were carried out at 30 °C with agitation (200 r.p.m.). Viability
was determined by CFU (colony-forming units) counts after a 2
day incubation on YEPD agar plates at 30 °C. No additional
colonies appeared after this period. Results were normalized to
O.D. 100% corresponds to the number of CFU at time zero.
Flow Cytometry
Flow cytometry data acquisition was performed with an Epics
XL-MCL (Beckman Coulter) flow cytometer equipped with an
argon-ion laser emitting a 488 nm beam at 15 mW. At least
twenty thousand cells were analyzed per sample at low flow
rate.
Fluorescence Microscopy
Cells were observed using a Leica Microsystems DM-5000B
epifluorescence microscope with appropriate filter settings
using a 100x oil-immersion objective. Images were acquired
with a Leica DCF350FX digital camera and processed with
LAS AF Leica Microsystems software.
Cell cycle analysis
Cell cycle analysis was performed as described [16] using 1
µM Sytox Green (Molecular Probes). Fluorescence was
measured by flow cytometry, and the data was analyzed using
FlowJo 7.6 software (Tree Star, Inc).
Cell synchronization in G0/G1 phase
Yeast cells were grown in SC galactose to mid-exponential
phase, and transferred to nitrogen starvation medium (SD–N
medium: 0.17% yeast nitrogen base without amino acids and
ammonium sulfate, 2% glucose) to an OD600 of 0.2. Cells were
then incubated at 30 °C for approximately 24 hours (one
duplication) and harvested.
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PI staining, ROS accumulation, chromatin
condensation assessment and detection of DNA strand
breaks
Plasma membrane integrity was assessed by propidium
iodide (PI) staining. 106 cells were incubated in culture medium
containing 2 µg/ml of PI (Sigma) at room temperature for 10
min, in the dark. Fluorescence was measured by flow
cytometry. Cells with red fluorescence [FL-3 channel (488/620
nm)] were considered to have lost plasma membrane integrity.
Reactive oxygen species (ROS) accumulation was monitored
by flow cytometry using Dihydroethidium (DHE) and other
probes (supplemental material). Intracellular generation of
superoxide anion was monitored using DHE (Molecular
Probes, Eugene, U.S.A.). 1×106 cells were harvested by
centrifugation, resuspended in PBS, and stained with 5 µg/ml
of dihydroethidium at 30 °C for 30 minutes, in the dark.
Fluorescence was measured by flow cytometry. Cells with red
fluorescence [FL-3 channel (488/620 nm)] were considered to
accumulate superoxide anion. ROS production assessment
using dihydrorhodamine 123 (DHR 123), 2′,7′-
Dichlorofluorescein diacetate (H2DCFDA) and Mitotracker Red
CM-H2XRos was performed as previously described [17].
For chromatin condensation assessment, cells were fixed
with ethanol, stained with DAPI (4,6-diamidino-2-phenylindole
dihydrochloride) and observed by fluorescence microscopy.
Viable cells were considered to have very round and clear
nuclei whereas apoptotic cells were identified by having
smaller, condensed (chromatin gathering at the periphery of
the nuclear membrane), fragmented and kidney shaped nuclei.
At least 300 cells per sample were counted in three
independent experiments and the percentage of apoptotic
nuclei determined.
The occurrence of DNA strand breaks was determined by
TUNEL assay using the In Situ Cell Death Detection Kit,
Fluorescein (Roche Applied Science, Indianapolis, IN) as
previously described [18]. Yeast cells treated with 30 µM of C2-
phytoceramide and 0.1% DMSO for 120 min were fixed with
3.7% (v/v) formaldehyde. The cell wall was digested with
Lyticase, and cells were applied to poly-lysine coated slides.
The slides were rinsed with PBS, incubated in permeabilization
solution (0.1% v/v, Triton X-100 and 0.1% w/v, sodium citrate)
for 2 min on ice, rinsed twice with PBS and incubated with 10 µl
TUNEL reaction solution for 60 minutes at 37 °C. Finally, the
slides were rinsed three times with PBS and a coverslip was
mounted with a drop of anti-fading agent Vectashield (Vector
Laboratories, Inc). Slides were analyzed by fluorescence
microscopy. Non-treated cells were used as a negative control
and DNase I treated cells were used as a positive control for
DNA breaks. Green fluorescence indicates TUNEL positive
cells. Samples were observed by fluorescence microscopy.
Sensitivity to Zymolyase
A zymolyase sensitivity assay was performed as described in
[19] with modifications. Wild-type yeast cells were cultivated in
SC 2% galactose medium with 30 µM of C2-phytoceramide or
0.1% DMSO for 2 h. Cells were then harvested, washed with
sterile distilled water and resuspended in 0.1 mM sodium
phosphate buffer (pH 7.5). After adding 20 µg/ml of zymolyase
(Medac; Medacshop), cell lysis was followed by measuring the
decrease in the OD600 of each cell suspension.
Filipin staining
Sterol-lipid distribution was assessed in vivo by filipin
staining as previously described [20].
Sensitivity to ergosterol biosynthesis inhibitors,
amphotericin B and methy- β-cyclodextrin
W303-1A cells were grown to mid-exponential-phase (OD600
of 0.5-0.6), harvested by centrifugation and suspended in SC
galactose (OD600 of 0.2). Cells were exposed for 30 min to: 300
µM clotrimazole, 300 µM ketoconazole, 5 mg/ml methyl-β-
cyclodextrin or 1µg/ml amphotericin B. Afterwards, 0.1% (v/v)
DMSO and 30 µM of C2-phytoceramide were added, and cells
were again incubated for 120 min at 30 °C with agitation (200
r.p.m.). Viability was determined by CFU counts as described
above. All chemicals were obtained at the highest available
grade (Sigma-Aldrich).
Statistical analysis
Two-way ANOVA or One-way with Bonferroni posttest was
performed using GraphPad Prism version 5.00 for Windows,
GraphPad Software, San Diego California USA
(www.graphpad.com). Two-way ANOVA analysis was
performed when evaluating two conditions, such as the impact
of stress caused by ceramides or DMSO (1° condition) along
time (2° condition). One-way ANOVA analysis was performed in
experiments evaluating just one condition, usually the stress
impact at one time point. The Bonferroni posttest was used
because it assumes that the tests are independent of each
other.
Results
C2-phytoceramide leads to loss of clonogenic survival
in Saccharomyces cerevisiae
Phytoceramides, the yeast counterparts of mammalian
ceramides, mediate regulation of cell growth and stress
responses in yeast. Exposure of mammalian cell lines to C2-
ceramide mimics the effect of ceramide generation in response
to chemotherapeutic drugs or other stress conditions [3]. In
order to explore yeast as a model system to further understand
the molecular basis of ceramide-induced effects, we tested
whether exogenously added phytoceramides, like ceramides in
mammalian cells, could induce cytotoxicity in yeast. Clonogenic
survival was assessed in Saccharomyces cerevisiae W303-1A
cells exposed to the soluble and cell-permeable phytoceramide
N-acetyl-phytosphingosine (C2-phytoceramide), N-acetyl-
sphingosine (C2-ceramide) or N-hexanoil-sphingosine (C6-
ceramide) for up to 240 min. C2-ceramide or C2-
phytoceramide decreased cell clonogenic survival, but CFU
counts of cells exposed to C6-ceramide were indistinguishable
from those of DMSO-treated control cells (Figure 1A). C2-
phytoceramide led to the highest decrease in CFU, which was
dose-dependent in the range of 10 to 40 µM and started to be
rapidly observed (Figure 1A, 1B). A similar sensitivity to C2-
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phytoceramide was also observed with another S. cerevisiae
strain background, showing that the effect was not specific for
W303-1A (Figure S1).
Next, we questioned whether C2-phytoceramide, as
described for C2-ceramide [7], could alter cell cycle
progression. C2-phytoceramide led to an accumulation of cells
in the G0/G1 phase (Figure 1C), similarly to that described for
C2-ceramide. To address whether C2-phytoceramide-induced
loss of CFU was cell-phase specific, cells were synchronized in
G0/G1 by incubation under nitrogen starvation for 24 hours
prior to treatment. G0/G1-synchronised cells were then
harvested, centrifuged and resuspended in the same starvation
medium or in liquid synthetic complete medium (SC), with C2-
phytoceramide (dissolved in DMSO) or with the same amount
of DMSO. Cells that were kept in the starvation medium, and
so not release from G0/G1 arrest, were not sensitive to C2-
phytoceramide (Figure 2A). In cells transferred to SC medium
with C2-phytoceramide, CFU started to decrease only when a
significant percentage of the population proceeded to the G2/M
phase, and was thus delayed relatively to unsynchronized cells
(Figure 2A and 2B). These results indicate that C2-
phytoceramide-induced decrease in CFU occurs preferentially
in dividing cells.
C2-phytoceramide does not elicit an apoptotic
phenotype or trigger autophagy
It had been shown that C2-ceramide induces mitochondrial-
dependent apoptotic and necrotic phenotypes in S. cerevisiae
BY4741 [13]. We therefore monitored cell death markers after
exposure to C2-phytoceramide. Exposure to C2-phytoceramide
did not lead to DNA fragmentation assessed by TUNEL
staining (Figure S2) and only slightly increased the
percentages of cells with positive propidium iodide (PI) staining
or with nuclear chromatin condensation (15%) visualized after
DAPI staining (Figure 3). Moreover, C2-phytoceramide did not
elicit mitochondrial alterations, including relevant ROS
accumulation assessed by staining with DHE, H2DCFDA/IP,
DHR 123 or Mitotracker Red (Figure S3), nor mitochondrial
fragmentation or degradation assessed using cells expressing
fluorescent mtGFP (Figure S4). Accordingly, C2-
phytoceramide-induced loss of CFU could not be rescued by
simultaneously treating cells with ROS scavengers (Figure
S5A), or by overexpressing the anti-apoptotic protein Bcl-XL
(Figure S5B), suggesting that mitochondrial function was not
involved in C2-phytoceramide-induced loss of CFU. In
agreement with this hypothesis, the sensitivity of a
mitochondrial-deficient mutant strain (rhoo) to C2-
phytoceramide was indistinguishable from that of the wild type
strain (Figure S5C). Deletion of the yeast metacaspase YCA1
also had no effect on the response to C2-phytoceramide, and
consistently caspase activation assessed by Z-VAD-FITC/IP
double staining was not detected (Figure S6). Taken together,
these results show that C2-phytoceramide does not induce an
apoptotic pathway in S. cerevisiae W303-1A cells.
Autophagy is a physiological process by which cells
sequester and degrade bulk cytosol and organelles for
recycling. It is important for the survival of cells under nitrogen
starvation conditions, but also has a housekeeping function in
removing damaged, redundant, or unwanted cellular
components [21]. In mammalian cells, autophagy can be
triggered by C2-ceramide, involving AKT/PKB, mTOR-signaling
and dissociation of the Beclin 1: Bcl-2 complex after c-Jun N-
terminal kinase 1 (JNK1)-dependent Bcl-2 phosphorylation
[22]. Under specific conditions and depending on cell type and
context, autophagy has also been proposed to mediate cell
death [22]. We therefore evaluated whether C2-phytoceramide
induced autophagy in wild-type cells, possibly contributing to
C2-phytoceramide-induced loss of CFU in S. cerevisiae. We
measured cleavage of Atg8-GFP, a commonly used marker of
autophagy, and also assessed the kinetics of C2-
phytoceramide-induced loss of CFU in the autophagy-defective
mutant atg5Δ. Exposure of wild-type cells to C2-phytoceramide
Figure 1.  S. cerevisiae cells are sensitive to ceramides.  (A) Survival of W303-1A cells exposed to 30 µM C2-phytoceramide
(∇), 30 µM C6-ceramide (*), 30 µM C2-ceramide (▼), or equivalent volume of solvent (■). CFU values of C2-treated cells
significantly different from DMSO-treated cells, P<0.0001, Two-Way ANOVA. (B) Survival of W303-1A cells exposed to 10 µM (●),
20 µM (○), 30 µM (∇-dashed lines) and 40 µM (♦-dashed lines) C2-phytoceramide, or equivalent volume of solvent (■). CFU values
of C2-phytoceramide-treated cells (30 µM or 40 µM) are significantly different from DMSO-treated cells for all time points, P<0.001,
Two-Way ANOVA. All CFU values (A and B) represent mean ± SE of at least 3 independent experiments, with 5 replicas in each
experiment. (C) Cell cycle progression of cells exposed to 30 µM C2-phytoceramide or equivalent volume of solvent. Data from a
representative experiment (of 3 independent experiments) is shown.
doi: 10.1371/journal.pone.0074240.g001
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did not lead to Atg8-GFP cleavage (Figure S7A) and,
consistently, absence of Atg5p did not rescue cells from C2-
phytoceramide induced loss of CFU (Figure S7B), thus
excluding a role for autophagy in this process.
Figure 2.  S. cerevisiae cells in G2/M are more sensitive to C2-phytoceramide.  (A) Survival of W303-1A cells synchronized in
nitrogen starvation medium. Cells were transferred to SC gal medium and then exposed to 30 µM C2-phytoceramide (▼-dashed
lines) or equivalent volume of solvent (■), or maintained in nitrogen starvation medium and exposed to 30 µM C2-phytoceramide (∇-
dashed lines) or equivalent volume of solvent (□). CFU values of cells transferred to SC gal and treated with 30 µM C2-
phytoceramide are significantly different from C2-phytoceramide treated cells kept in nitrogen starvation medium and from DMSO-
treated cells transferred or not to SC Gal, for all time points, P<0.001, Two-Way ANOVA. All CFU values represent mean ± SE of at
least 3 independent experiments, with 5 replicas in each experiment. (B) Cell cycle progression of the cells described in (A). Data
represent mean ± SE of at least 3 independent experiments.
doi: 10.1371/journal.pone.0074240.g002
Figure 3.  Cell death markers observed after exposure of S. cerevisiae to C2-phytoceramide.  (A) Percentage of PI positive
cells in W303-1A cultures exposed to C2-phytoceramide or to equivalent volume of solvent. Values represent mean ± SE of at least
3 independent experiments. Percentages of PI-stained cells of C2-phytoceramide-treated cells (30 µM and 40 µM) significantly
different from DMSO-treated cells, P<0.001 for time 60 and 120 min and P<0.01 for time 180 min, Two-Way ANOVA. (B)
Percentage of yeast cells with chromatin condensation, determined by counting at least 300 cells per sample after a 120 min
treatment with 30 µM C2-phytoceramide or equivalent volume of solvent, in three independent experiments. P<0.05 One-Way
ANOVA.
doi: 10.1371/journal.pone.0074240.g003
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Cell integrity defects underlie C2-phytoceramide-
induced loss of CFU
Since there was no significant increase in apoptotic or
autophagic markers in cultures treated with C2-phytoceramide,
we questioned if hypo-osmotic stress associated with dilution of
the samples in sterile water before plating, a manipulation
performed only for clonogenic assays, was responsible for the
decrease in CFU. Diluting cells in culture medium instead of
sterile water before plating indeed partially prevented the loss
of clonogenic survival, and this protection increased if the
osmoprotector trehalose was added to the dilution medium
(Figure 4A). In addition, in contrast with cells diluted in medium,
diluting the cells in water led to a massive permeabilization to
PI, indicative of necrosis (Figure 4B). This effect was specific to
C2-phytoceramide, as there was no difference in membrane
permeability to PI of cells exposed to C2-ceramide either when
diluted in water or in medium (Figure 4B). Exposure of cells to
C2-phytoceramide also led to increased susceptibility to
digestion with the cell wall-degrading enzyme zymolyase,
which again was not observed for C2-ceramide, suggesting
that defects in cell wall integrity underlie C2-phytoceramide-
induced loss of CFU (Figure 4C). Since C2-phytoceramide
effects were particularly evident in cells in the G2/M phase
(Figure 2), these results support the idea that C2-
phytoceramide perturbs cell wall assembly. We therefore next
studied how C2-phytoceramide affects lipid rafts, as defects in
these plasma membrane structures can perturb cell wall
assembly [23].
C2-phytoceramide perturbs ergosterol distribution in
lipid rafts
Rafts are membrane lipid microdomains formed by lateral
association of sphingolipids and ergosterol in yeasts,
indispensable for the anchoring of proteins responsible for cell
wall biogenesis and assembly [24]. They play fundamental
roles in connecting the plasma membrane to the cytoskeleton
and endoplasmic reticulum and Golgi apparatus, i.e., for
correct protein sorting and trafficking through exocytosis/
endocytosis [24]. To test whether defects in cell integrity were a
consequence of an alteration in lipid rafts mediated by C2-
phytoceramide, we monitored cellular ergosterol distribution
using filipin, a polyene antibiotic with fluorescent properties that
binds sterols. The characteristic dot staining of rafts at the
plasma membrane were decreased in C2-phytoceramide-
treated cells, while staining of intracellular structures was
increased; C2-ceramide had no effect on filipin distribution
(Figure 5A,B). To confirm that the decreased plasma
membrane staining corresponded to a decrease in ergosterol
content, we treated cells with methyl-β-cyclodextrin, which
extracts ergosterol from membranes [25]. Treatment with this
compound yielded a similar filipin-staining pattern as C2-
phytoceramide (Figure 5A). Furthermore, pre-treatment of cells
with inhibitors of ergosterol biosynthesis, with methyl-β-
cyclodextrin, or with the ergosterol-binding antibiotic
amphothericin B, increased resistance to C2-phytoceramide
(Figure 6A). Taken together, these results indicate that
exposure of S. cerevisiae cells to C2-phytoceramide leads to a
perturbation in the sterol-rich membrane micro-domains known
Figure 4.  C2-phytoceramide sensitizes S. cerevisiae to hyposmotic stress and leads to defects in cell wall integrity.  (A)
Survival of W303-1A cells exposed to 30 µM C2-phytoceramide or equivalent volume of solvent (■). Before plating on solid media,
cells were diluted in water (∇), SC medium (Δ), or SC medium with 2% trehalose (○). Data are given as mean ± SE of 3
independent experiments, with 5 replicas in each experiment. CFU values of C2-phy treated cells diluted in water were significantly
different from C2-phy treated cells diluted in medium + trehalose, P<0.001, Two-Way ANOVA. Viability of C2-phy treated cells
diluted in water were significantly different from C2-phy treated cells diluted in medium, P<0.01 for time 60 min and P<0.001 for time
120 min, Two-Way ANOVA. CFU values of C2-phy treated cells diluted in medium were significantly different from C2-phy treated
cells diluted in medium + trehalose, P<0.01 for time 60 min and P<0.05 for time 120 min, Two-Way ANOVA (B) Percentage of P.I.
positive cells, after treatment with 0.1% DMSO, 30 µM of C2-phytoceramide, or 40 µM of C2-ceramide for 120 min. Cells were
diluted 100x in water and in SC medium and then stained with 2 µg/ml PI for 10 min in the dark. P<0.001 One-Way ANOVA. (C)
Sensitivity of W303-1A cells exposed to 30 µM C2-phytoceramide (∇), 40 µM C2-ceramide (▲) or equivalent volume of solvent (☐)
to digestion with zymolyase. Non-treated cells were used as a control (○). Values represent mean ± SE of 3 independent
experiments. C2-phytoceramide treated cells were significantly different from non-treated and DMSO treated cells, P<0.001, Two-
Way ANOVA.
doi: 10.1371/journal.pone.0074240.g004
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as lipid rafts and suggest ergosterol is the target of C2-
phytoceramide. The perturbation of lipid rafts was also
evaluated by observing the distribution of Pma1p, the plasma
membrane ATPase that localizes in these structures. C2-
phytoceramide led to a uniform rather than punctuated pattern
of a GFP-tagged version of Pma1p at the plasma membrane in
a high percentage of cells (Figure 5C).
We next assessed the impact of perturbing lipid rafts on the
response to C2-phytoceramide using the rvs161Δ mutant. The
Rvs161 protein is localized in lipid rafts and is involved in
cytoskeleton organization, cell polarity and cell wall synthesis,
as well as in cell survival following osmotic stress [26].
Absence of Rvs161p resulted in increased sensitivity to C2-
phytoceramide, but not to C2-ceramide (Figure 6B). These
results confirm the involvement of raft-mediated processes in
the loss of CFUs induced by C2-phytoceramyde during cell
growth. Since Rvs161p is involved in cytoskeleton
organization, we questioned if C2-phytoceramide induces
alterations in actin organization. However, treatment with this
compound did not result in an altered pattern of rhodamine
phalloidin staining (Figure S8).
The HOG pathway increases resistance to C2-
phytoceramide
Two Mitogen Activated Protein Kinase (MAPK) pathways of
the yeast Saccharomyces cerevisiae are important in the
response to osmotic stress, the cell wall integrity (CWI)
pathway, essential for the response to hypo-osmotic stress,
and the High Osmolarity Glycerol (HOG) response pathway.
We therefore tested the response of strains deficient in
different components of these two pathways to C2-
phytoceramyde. slt2Δ, wsc2Δ, wsc3Δ, mid2Δ and bck1Δ cells,
deficient in components of the CWI pathway, displayed no
differences in response to this compound (Figure 7),
Figure 5.  Distribution of sterol-rich domains in S. cerevisiae cells exposed to C2-phytoceramide.  (A) Fluorescence
microscopy pictures of W303-1A cells exposed to 30 µM C2-phytoceramide, 40 µM C2-ceramide, 5 mg/ml methyl-®-cyclodextrin or
0.1% DMSO for 120 min and stained with filipin (5 mg/ml). (B) Percentage of yeast cells with ergosterol displacement. Cells were
treated as described in (A) and the number of cells with ergosterol displacement was determined by counting at least 120 cells per
sample, in three independent experiments. P<0.01 respectively, One-Way ANOVA. (C) Percentage of yeast cells with perturbed
Pma1p-GFP distribution. W303-1A cells were transformed with a single copy vector derived from pRS316 expressing Pma1p-GFP
(3). At least 300 cells per sample were counted. P<0.01.
doi: 10.1371/journal.pone.0074240.g005
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suggesting that the CWI pathway does not signal sensitization
to osmotic stress in response to C2-phytoceramide.
The HOG pathway has a central role in resistance and
adaptation to osmotic stress, through both transcriptional and
non-transcriptional responses [27]. We tested mutant strains
lacking the Hog1p MAPK, ortholog of the human JNK and p38,
and components of the two upstream signaling branches,
namely, Sln1p, Ssk1p and Ste20p. hog1Δ, sln1Δ and ssk1Δ
mutant strains were more sensitive to C2-phytoceramide than
wild-type cells, whereas the ste20Δ strain was more resistant
(Figure 7), indicating that the Sln1p branch of the HOG
pathway, but not the Sho1p branch, is important for resistance
to C2-phytoceramide-induced loss of CFU. It has been
reported that perturbation of raft structure by filipin impedes
activation of the Sho1p branch [28]. This may explain the
involvement of Sln1p branch, rather than Sho1p, in the
response to C2-phytoceramide, which we also found disturbs
lipid rafts.
The Ste20p kinase is a component of three signaling
cascades in yeast that control the osmoregulatory response to
hypertonic stress (HOG pathway), the pheromone response,
and filamentous growth pathways. The involvement of Ste20p
in these last two pathways could explain the resistance
phenotype of the deletion mutant. Absence of the G-protein–
coupled yeast a-pheromone receptor Ste3p increased
resistance to C2-phytoceramide, while deficiency in the -
pheromone receptor Ste2p and in Kss1p, a downstream
component of the filamentous growth pathway, did not affect
this response (Figure 7). Taken together, these results suggest
that the ste20Δ resistance phenotype may stem from its
involvement in the pheromone response pathway.
Since our results show that Hog1p is important for the
resistance to C2-phytoceramide, we tested if this compound
could induce Hog1p activation. There was a moderate Hog1p
phosphorylation, at time zero, indicating that the Hog pathway
was already activated under our experimental conditions. After
5 min of incubation with C2-phytoceramide there was a slight
increase in Hog1p phosphorylation, though not statistically
different when compared with vehicle DMSO-treated control
cells (Figures S9A and S9B). Consistently with Hog1 basal
activation, pre-incubation with sorbitol before treatment with
C2-phytoceramide did not affect cell survival (Figure S9C). The
results indicate that the presence of active Hog1p is
responsible for promoting resistance to osmotic stress and are
consistent with the sensitive phenotype of the hog1Δ mutant.
Discussion
In the last decades, ceramides have been implicated in the
regulation of cell proliferation and cell death in both mammalian
and yeast cells [29]. Therefore, interfering with ceramide
metabolism or direct exposure to ceramides have been
explored as potential therapeutic strategies for diseases
Figure 6.  Loss of cell viability is rescued by ergosterol biosynthesis inhibitors, amphotericin B and methyl-β-
cyclodextrin.  (A) Survival of W303-1A cells exposed to amphotericin B 1 µg/ml, ketoconazole 300 µM, clotrimazole 300 µM or
methyl-β-cyclodextrin 5 mg/ml for 30 min followed by an incubation with C2-phytoceramide for 120 min. Values represent mean ±
SE of at least 3 independent experiments, with 5 replicas in each experiment. (B) Survival of wild type W303-1A and rvs161Δ cells
exposed to 30 µM C2-phytoceramide or 30 µM C2-ceramide. CFU values of the C2-phytoceramide-treated mutant cells are
significantly different from wild type-treated cells P<0.01, One-Way ANOVA.
doi: 10.1371/journal.pone.0074240.g006
Ceramide Perturbs Lipid Rafts and Cell Integrity
PLOS ONE | www.plosone.org 8 September 2013 | Volume 8 | Issue 9 | e74240
associated with dysfunctional cell fate regulation [30]. In this
study, we aimed to explore yeast as a model system to unravel
the still poorly understood mechanisms and signaling pathways
underlying ceramide cytotoxicity. We characterized the effect of
C2-phytoceramide, a yeast counterpart of mammalian
ceramides, on the viability of Saccharomyces cerevisiae
W303-1A cells. In accordance with a previous study with SK–
N-BE(2) C and N1E-115 mammalian cell lines [31], C2-
phytoceramide led to a decrease in CFU, but not to typical
apoptotic markers. Accordingly, C2-phytoceramide cytotoxicity
could not be inhibited by ROS scavengers or by
overexpression of the anti-apoptotic protein Bcl-xL. In
agreement with the lack of caspase activation, absence of the
yeast metacaspase Yca1p did not rescue cells from C2-
phytoceramide cytotoxicity. This is in accordance with the
previously described caspase-independent cell death induced
by C2-ceramide in S. cerevisiae BY4741 cells [13], although
our results show that cytotoxicity induced by C2-phytoceramide
differs significantly from that of C2-ceramide, namely because
it does not depend on mitochondrial function.
It was reported that ceramide induces autophagy in
mammalian cells by interfering with different signaling
pathways [22]. Therefore, we hypothesized that excessive
autophagy could underlie the observed sensitive phenotype.
However, C2-phytoceramide did not trigger autophagy and
sensitivity was not affected in the absence of Atg5p. A previous
report indicating that the yeast proteins Ipt1p and Skn1p,
involved in the biosynthesis of mannosyldiinositolphosphoryl
Figure 7.  The MAP kinase pathways are involved in the
sensitization of S. cerevisiae to C2-
phytoceramide.  Survival of wild type W303-1A cells and of
mutant strains after exposure to 30 µM C2-phytoceramide for
120 min. (ssk1Δ, P<0.0001, sln1Δ, P<0.0001 hog1, P<0.01
and ste20Δ, P<0.05), (ste3Δ, P<0.05), One-Way ANOVA. Data
are given as mean ± SE of at least 3 independent experiments,
with 5 replicas in each experiment.
doi: 10.1371/journal.pone.0074240.g007
ceramides, negatively regulate autophagy induced by nitrogen
(N) starvation [32] may explain our results.
C2-phytoceramide, as previously described for C2-ceramide
[7], affects yeast cell cycle progression, inducing a delay in
G0/G1. We found that sensitivity to C2-phytoceramide was also
cell cycle-specific, as it was observed preferentially in G2/M
phase cells. This observation is consistent with a report
showing that pro-B-cell lymphoid cultures (FL5.12) growing in
the presence of high levels of IL-3 growth factor are more
sensitive to ceramide than cells maintained in low levels of this
compound [33]. It would also explain why cancer cells, usually
dividing more actively, are more sensitive to ceramide than
non-dividing cells.
Our results indicate that exposure of cells to C2-
phytoceramide causes defects in the cell wall, rendering them
more sensitive to digestion with zymolyase. This sensitization
was not due to nonspecific detergent-like effects on the plasma
membrane, as it was not observed for the structurally close C2-
ceramide. Rather, it appears to be associated with defects in
ergosterol distribution and lipid rafts. This is in line with
previous reports using lipid vesicles containing co-existing raft
domains and disordered fluid domains, which showed that
ceramides displaced cholesterol from rafts while other raft
lipids remained raft-associated in the presence of ceramides
[34]. Filipin staining of C2-phytoceramide-treated cells and the
resistance of ergosterol-depleted cells to C2-phytoceramide
support that C2-phytoceramide may have a similar effect on
yeast lipid rafts, displacing ergosterol, the yeast equivalent of
mammalian cholesterol. Two other observations support this
hypothesis: the sensitive phenotype of the rvs161Δ strain and
the C2-phytoceramide-induced change in the distribution of the
plasma membrane ATPase Pma1p from its usual punctuated
pattern to a uniform distribution. Disruption of these structured
membrane microdomains may compromise different essential
cell functions, including cell wall and plasma membrane
synthesis in dividing yeast cells. Moreover, it was recently
shown that components of lipid rafts, namely ergosterol,
regulate the HOG pathway [35]. Accordingly, absence of
Hog1p drastically increased cell susceptibility, reinforcing that
C2-phytoceramide cytotoxicity can be counterbalanced by the
protection against osmotic stress afforded by Hog1p. Hog1p is
also involved in the inhibition of ergosterol biosynthesis in
response to hypoxia stress [36]. The higher sensitivity of the
hog1Δ mutant might therefore be a result of an increase in
ergosterol content in this strain, as we also observed that
inhibiting ergosterol biosynthesis increased resistance to C2-
phytoceramide.
Absence of the pheromone response pathway components
Ste3p and Ste20p resulted in higher resistance to C2-
phytoceramide-induced loss of CFU. These results are
consistent with the observed G1 cell cycle arrest and
weakening of the cell wall induced by C2-phytoceramide, since
these are two well-characterized effects associated with the
activation of the pheromone response pathway [37]. This
pathway has been implicated in necrotic cell death in response
to pheromone [37], and our results suggest that it can also be
involved in the mediation of necrotic cell death in response to
C2-phytoceramide. However, the involvement of this pathway
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needs further clarification as STE3 deletion is not expected to
have a phenotype in a mating type a (Mata) strain, where
Ste3p expression is repressed [38].
Since lipid rafts are also important in signaling and the
organization of the cell wall-like extracellular matrix in
mammalian cells, the results presented here suggest that
different effects of ceramide previously described, such as
anoikis induction in HeLa cells [39] or altered signaling
described for many cell systems, may be associated with a
similar disorganization of lipid rafts. This study identified a new
function of C2-phytoceramide through interference with cell
wall stability, likely mediated by the disorganization of lipid
rafts. Our results also substantiate that manipulation of MAPK
pathways or changes in sterol content or availability at the
plasma membrane can modulate sensitivity to C2-
phytoceramide. Since breast and prostate cancer cell lines
contain more cholesterol-rich lipid rafts than their normal
counterparts [40], our results showing that high levels of sterols
render cells more sensitive to C2-phytoceramide suggest that
cancer cells can be potential preferential targets for this
compound. Furthermore, pharmacological modulation of the
conserved MAPK pathways involved in ceramide signaling can
also result in increased sensitivity to C2-phytoceramide. As a
whole, our results further support pursuing the use of yeast
cells as a model system to elucidate the effects of synthetic
ceramides and provide improved understanding of the
molecular basis of their action with potential implications in the
discovery of novel strategies for therapeutic intervention in
different diseases.
Supporting Information
Figure S1.  S. cerevisiae W303-1A and BY4741 cells are
sensitive to C2-phytoceramide. Survival of W303-1A (full
lines) and BY4741 (dashed lines) cells exposed to 30 µM C2-
phytoceramide (●,♦) or equivalent volume of solvent (■, ▲).
CFU values of C2-treated cells significantly different from
DMSO-treated cells, P<0.001, Two-Way ANOVA. All CFU
values represent mean ± SE of at least 3 independent
experiments, with 5 replicas in each experiment.
(PDF)
Figure S2.  C2-phytoceramide does not induce DNA
fragmentation assessed by TUNEL. A. Fluorescence images
of TUNEL staining of S. cerevisiae W303-1A treated with 30
µM of C2-phytoceramide or 0.1% (v/v) DMSO for 120 min.
Non-treated cells were used as a negative control and DNase I
treated cell were used as a positive control for DNA breaks. B.
Fluorescence images of TUNEL staining of S. cerevisiae
W303-1A treated with 180 mM of acetic acid for 150 min, used
as a positive control for induction of DNA breaks during an
apoptotic process [41]. The occurrence of DNA strand breaks
was determined using the In Situ Cell Death Detection Kit,
Fluorescein (Roche Applied Science, Indianapolis, IN) as
previously described [18].
(PDF)
Figure S3.  C2-phytoceramide does not lead to significant
ROS accumulation. ROS production in S. cerevisiae W303-1A
cells exposed to 30 µM C2-phytoceramide or equivalent
volume of solvent (0.1% v/v, DMSO) for up 120 min was
measured by flow cytometry using: A. dihydroethidium (DHE):
Differences between C2-phytoceramide and DMSO treated
cells are not significant, P > 0.05 (ns) One-Way ANOVA. Data
are given as mean ± SE of at least 3 independent experiments,
with 5 replicas in each experiment; B. dihydrorhodamine 123
(DHR 123): For T0, P > 0.05 (ns), T60, P<0.001 and for T120,
P<0.01. Two-Way ANOVA. Data are given as mean ± SE of 3
independent experiments; C. 2′, 7′-Dichlorofluorescein
diacetate (H 2DCFDA): Differences between C2-phytoceramide
and DMSO treated cells are not significant, P > 0.05 (ns) Two-
Way ANOVA; D. Mitotracker Red CM-H2XRos :. For T0 and
T60, P>0.05 (ns), and for T120, P<0.05. Two-Way ANOVA.
Data are given as mean ± SE of 3 independent experiments.
Intracellular generation of superoxide anion was monitored
using DHE, (Molecular Probes, Eugene, U.S.A.). 1×106 cells
were harvested by centrifugation, resuspended in PBS, and
stained with 5 µg/ml of dihydroethidium at 30 °C for 30 minutes,
in the dark. Fluorescence was measured by flow cytometry. For
detection of intracellular ROS with dihydrorhodamine 123
(DHR123) (Molecular Probes, Eugene, OR, USA) a 2.5 mg/ml
stock solution in DMSO was added to 106 cells/ml suspended
in PBS, to a final concentration of 15 µg/ml. Cells were
incubated at 30°C for 90 minutes, in the dark. Results are
expressed as ratio values estimated by dividing the mean
fluorescence intensity of each sample by the mean
fluorescence intensity of time zero. For detection of ROS with
H 2DCFDA (Molecular probes), a double staining protocol with
PI was used. Conversion of H 2DCFDA to DCF was analyzed in
PI negative cells. 106 cells were incubated in culture medium
containing 40 µg/ml H2DCFDA at 30 °C for 45 min, in the dark.
2 µg/milliliter of PI was added after 30 min of incubation. For
detection of ROS with Mitotracker Red CM-H2XRos (Molecular
Probes, Eugene, OR) 0.5x107 cells were resuspended in 500
µL of PBS with 1 mM of the probe, and incubated at 37 °C for
20 min, in the dark.
(PDF)
Figure S4.  C2-phytoceramide does not induce
mitochondrial fragmentation and degradation. A.
Mitochondrial morphology of S. cerevisiae W303-1A cells
expressing mitochondrial targeted GFP (W303-1A transformed
with pYES2-mtGFP), treated with 30 µM C2-phytoceramide or
with 0.1% (v/v) DMSO for 120 min. Non-treated cells (time 0)
were used as a control. B. Quantification of the percentage of
cells displaying GFP fluorescence over the treatment described
in (A). Loss of GFP fluorescence was used as a measure of
mitochondrial degradation. Values are mean ± SE of 3
independent experiments.
(PDF)
Figure S5.  Loss of cell viability induced by C2-
phytoceramide could not be inhibited by 20 µM of N-
acetylcysteine (NAC), by overexpression of the anti-
apoptotic protein Bcl-xL or in a rho0 mutant. A. Survival of
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S. cerevisiae W303-1A cells exposed to 30 µM C2-
phytoceramide (○), 30 µM C2-phytoceramide and 20 µM NAC
(●), 0.1% (v/v) DMSO (□) and 0.1% (v/v) DMSO with 20 µM
NAC (■) for up to 120 min. B. Survival of S. cerevisiae
W303-1A cells overexpressing Bcl-xL, exposed to 30 µM C2-
phytoceramide (▼) or 0.1% (v/v) DMSO (●) for up to 180 min.
W303-1A cells harboring the empty plasmid (pYES2) treated
with 30 µM C2-phytoceramide (○) or 0.1% (v/v) DMSO (□). C.
Survival of S. cerevisiae W303-1A cells (∇) and rho0 mutant (*)
exposed to 30 µM C2-phytoceramide for up to 120 min. In all
experiments 100% corresponds to the number of CFU at time
zero. Values are means ± SE of 3 independent experiments.
(PDF)
Figure S6.  Caspases activation and Yca1p are not
involved in C2-phytoceramide-induced loss of CFU. A.
Caspase activation assessed by flow cytometry using
‘CaspACE, FITC-VAD-fmk In Situ Marker’ (Promega) with or
without PI staining using a protocol adapted from [42] (3). S.
cerevisiae W303-1A cells were exposed to 30 µM C2-
phytoceramide or 0.1% (v/v) DMSO for 60 minutes, single
stained with FITC or with PI, and double stained with FITC and
PI. Most of the cells displaying FITC staining also exhibited
compromised membrane integrity (PI staining). B. Survival of
the metacaspase mutant Δyca1 cells after exposure to 30 µM
C2-phytoceramide or equivalent volume of solvent (0.1% v/v,
DMSO) for 120 min.
(PDF)
Figure S7.  C2-phytoceramide does not trigger autophagy.
A. Western blot of whole cell extracts from W303-1A cells
expressing GFP-ATG8, before (time 0) and after exposure to
30 µM C2-phytoceramide (C2-Phy), or equivalent volume of
solvent (DMSO) for 120 min. Positive control (C+) represents
cells grown on nitrogen starvation medium for 24 h. The GFP-
Atg8 fusion was detected using an anti-GFP antibody (lower
panel). The amount of Pgk1 protein was used as a loading
control, and detected with an anti-PGK1 antibody (upper
panel). B. Survival of S. cerevisiae W303-1A and atg5Δ mutant
cells exposed to 30 µM C2-phytoceramide for 120 min. 100%
corresponds to the number of CFU at time zero. Values are
means ± SE of 3 independent experiments.
(PDF)
Figure S8.  C2-phytoceramide doesn’t interfere with actin
polarization in S. cerevisiae. W303-1A cells were grown in
SC galactose to mid-exponential-phase, exposed to 0.1% (v/v)
DMSO and 30 µM of C2-phytoceramide, fixed for 15-30 min in
300 µl of formaldehyde 3.7%, and permeabilized with 0.1%
Triton X-100 in PBS. After washing 2x with 300 µl of PBS, cells
were stained with 1 µl (3 units, from 200 units/ml stock solution)
phalloidine rhodamine for 20 min.
(PDF)
Figure S9.  Phosphorylation of Hog1p and effect of pre-
incubation under osmotic stress in C2-phytoceramide-
induced loss of CFU. Cells of the W303-1A wild-type (wt)
strain were grown in SC galactose to mid-exponential-phase
(OD600 =0.5-0.6), diluted to OD600= 0.2 and then exposed to 30
µM of C2-phytoceramide, or equivalent volume of solvent
(0.1% v/v, DMSO) for up to 30 min. At the indicated times, cells
were harvested and processed, and the crude protein extracts
were analyzed by Western blot. Wt cells grown in YPD medium
at 30 °C, non-treated (YPD) or treated with 1 M NaCl-stressed
cells (NaCl) for 5 min. were used as control. Total protein
extracts were analyzed by SDS-PAGE and blotting with anti-
phospho-p38 antibody, which cross-reacts with the dual
phosphorylated form of Hog1p (P-Hog1p). The lower
membranes were blotted with anti-Hog1p (Hog1p) and with
anti-PGK1 (Pgk1p) antibodies as loading controls. B.
Quantification of P-Hog1p level over time for the experiments
described in (A). Cytosolic phosphoglycerate kinase (Pgk1p)
level was used to normalize protein amount loaded on the gel.
Values are means ± SD of three independent experiments. C.
Percentage of P.I. positive cells, of cells grown to mid-
exponential-phase, exposed 10 min to sorbitol 1M (for Hog1p
activation), followed by incubation with 30 µM of C2-
phytoceramide and 0.1% (v/v) DMSO for up to 120 min.
(PDF)
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